Last reviewed · How we verify
NCT04923503
Diurnal Ramadan Fasting on Appetite Hormone and Metabolic Profile Among Lean, Obesity, Diabetics
NA trial testing diurnal fasting in Fasting in 45 participants. Completed in 1 May 2021.
12 April 2021
Quick facts
| Lead sponsor | Universitas Diponegoro |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 1 March 2021 |
| Primary completion | 12 April 2021 |
| Estimated completion | 1 May 2021 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- diurnal fasting
Conditions studied
- Fasting — all drugs for Fasting →
- Gut Hormone — all drugs for Gut Hormone →
Sponsor
Universitas Diponegoro — full company profile →
Who can join
Adults 35 to 60, any sex, with Fasting or Gut Hormone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Diabetes Mellitus individuals are known to have dietary rules, namely regulating the amount, type and time of eating. Ramadan fasting seems to be beneficial for people who want to reduce their weight, but it is not easy for diabetic patients. Because of its distinctive features, Ramadhan induces changes in eating habits, calorie consumption, sleeping patterns, and daily physical activity, which may contribute to changes in hunger-satiety responses and glicemic control. Examining changes in gut hormones during Ramadan fasting may reveal whether this observance could change glucose metabolism in diabetics without triggering the undesirable effect of gluconeogenesis. The proportions of fat, protein, and carbohydrate in meals vary between outside and within Ramadan. Alterations in timing and composition meal during Ramadan lead to reduced food intake may affect gut hormones and metabolic responses. The aim of this study to determine whether the effect of Ramadan fasting differed in people with DM patients, pre-DM and healthy individuals, with respect to gut hormones, body composition, metabolic parameters, and glycemic control
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04923503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fasting
Currently open trials in the same condition.
- NCT07216989 — Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting · recruiting
- NCT06737224 — The Impact of a 48-hour Fast with or Without Exercise on Immune Cell Metabolism and Glycemic Control in Healthy Active A · NA · recruiting
- NCT06779201 — Fasting Effects on Metabolism and Immunity Study in Human · NA · recruiting
- NCT06420739 — The Semaglutide Study · active not recruiting
- NCT06878781 — Postprandial Metabolome and Metabolic Flexibility · NA · recruiting
Other Universitas Diponegoro trials
Trials by the same sponsor.
- NCT07011199 — Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia · Phase 1 · not yet recruiting
- NCT07149961 — Curcumin-Piperine Supplementation in STEMI - SPICE STEMI Trial · NA · completed
- NCT07058857 — The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocard · NA · recruiting
- NCT06475105 — Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes · Phase 4 · recruiting
- NCT06448624 — Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04923503 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitas Diponegoro
- Last refreshed: 29 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04923503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing